Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia

K. Khan, M. Zech, AT. Morgan, DJ. Amor, M. Skorvanek, TN. Khan, MS. Hildebrand, VE. Jackson, TS. Scerri, M. Coleman, KA. Rigbye, IE. Scheffer, M. Bahlo, M. Wagner, DD. Lam, R. Berutti, P. Havránková, A. Fečíková, TM. Strom, V. Han, P. Dosekova,...

. 2019 ; 21 (11) : 2532-2542. [pub] 20190430

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023521

Grantová podpora
P50 DK096415 NIDDK NIH HHS - United States
R01 HD042601 NICHD NIH HHS - United States
R01 MH106826 NIMH NIH HHS - United States

PURPOSE: The purpose of this study was to expand the genetic architecture of neurodevelopmental disorders, and to characterize the clinical features of a novel cohort of affected individuals with variants in ZNF142, a C2H2 domain-containing transcription factor. METHODS: Four independent research centers used exome sequencing to elucidate the genetic basis of neurodevelopmental phenotypes in four unrelated families. Following bioinformatic filtering, query of control data sets, and secondary variant confirmation, we aggregated findings using an online data sharing platform. We performed in-depth clinical phenotyping in all affected individuals. RESULTS: We identified seven affected females in four pedigrees with likely pathogenic variants in ZNF142 that segregate with recessive disease. Affected cases in three families harbor either nonsense or frameshifting likely pathogenic variants predicted to undergo nonsense mediated decay. One additional trio bears ultrarare missense variants in conserved regions of ZNF142 that are predicted to be damaging to protein function. We performed clinical comparisons across our cohort and noted consistent presence of intellectual disability and speech impairment, with variable manifestation of seizures, tremor, and dystonia. CONCLUSION: Our aggregate data support a role for ZNF142 in nervous system development and add to the emergent list of zinc finger proteins that contribute to neurocognitive disorders.

Center for Human Disease Modeling Duke University Medical Center Durham NC USA

Center for Human Disease Modeling Duke University Medical Center Durham NC USA Department of Biological Sciences National University of Medical Sciences Rawalpindi Pakistan

Center for Human Disease Modeling Duke University Medical Center Durham NC USA Human Molecular Genetics Laboratory Health Biotechnology Division National Institute for Biotechnology and Genetic Engineering Islamabad Pakistan

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General Faculty Hospital Prague Czech Republic

Department of Neurology P J Safarik University Kosice Slovak Republic Department of Neurology University Hospital of L Pasteur Kosice Slovak Republic

Epilepsy Research Centre Department of Medicine University of Melbourne Austin Health Heidelberg VIC Australia

Epilepsy Research Centre Department of Medicine University of Melbourne Austin Health Heidelberg VIC Australia University of Melbourne Department of Paediatrics Royal Children's Hospital and Florey and Murdoch Children's Research Institute Parkville VIC Australia

Human Molecular Genetics Laboratory Health Biotechnology Division National Institute for Biotechnology and Genetic Engineering Faisalabad Pakistan

Human Molecular Genetics Laboratory Health Biotechnology Division National Institute for Biotechnology and Genetic Engineering Islamabad Pakistan

Institut für Humangenetik Helmholtz Zentrum München Munich Germany

Institut für Humangenetik Technische Universität München Munich Germany Institut für Humangenetik Helmholtz Zentrum München Munich Germany

Institute of Medical Genetics Medical School of Vienna Vienna Austria

Institute of Neurogenomics Helmholtz Zentrum München Munich Germany

Institute of Neurogenomics Helmholtz Zentrum München Munich Germany Institut für Humangenetik Technische Universität München Munich Germany

Institute of Neurogenomics Helmholtz Zentrum München Munich Germany Institut für Humangenetik Technische Universität München Munich Germany Lehrstuhl für Neurogenetik Technische Universität München Munich Germany Munich Cluster for Systems Neurology SyNergy Munich Germany

Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics Royal Children's Hospital Parkville Australia

Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics Royal Children's Hospital Parkville Australia Epilepsy Research Centre Department of Medicine University of Melbourne Austin Health Heidelberg VIC Australia

Population Health and Immunity Division The Walter and Eliza Hall Institute of Medical Research and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics Parkville VIC Australia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023521
003      
CZ-PrNML
005      
20201214130253.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41436-019-0523-0 $2 doi
035    __
$a (PubMed)31036918
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Khan, Kamal $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
245    10
$a Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia / $c K. Khan, M. Zech, AT. Morgan, DJ. Amor, M. Skorvanek, TN. Khan, MS. Hildebrand, VE. Jackson, TS. Scerri, M. Coleman, KA. Rigbye, IE. Scheffer, M. Bahlo, M. Wagner, DD. Lam, R. Berutti, P. Havránková, A. Fečíková, TM. Strom, V. Han, P. Dosekova, Z. Gdovinova, F. Laccone, M. Jameel, MR. Mooney, SM. Baig, R. Jech, EE. Davis, N. Katsanis, J. Winkelmann,
520    9_
$a PURPOSE: The purpose of this study was to expand the genetic architecture of neurodevelopmental disorders, and to characterize the clinical features of a novel cohort of affected individuals with variants in ZNF142, a C2H2 domain-containing transcription factor. METHODS: Four independent research centers used exome sequencing to elucidate the genetic basis of neurodevelopmental phenotypes in four unrelated families. Following bioinformatic filtering, query of control data sets, and secondary variant confirmation, we aggregated findings using an online data sharing platform. We performed in-depth clinical phenotyping in all affected individuals. RESULTS: We identified seven affected females in four pedigrees with likely pathogenic variants in ZNF142 that segregate with recessive disease. Affected cases in three families harbor either nonsense or frameshifting likely pathogenic variants predicted to undergo nonsense mediated decay. One additional trio bears ultrarare missense variants in conserved regions of ZNF142 that are predicted to be damaging to protein function. We performed clinical comparisons across our cohort and noted consistent presence of intellectual disability and speech impairment, with variable manifestation of seizures, tremor, and dystonia. CONCLUSION: Our aggregate data support a role for ZNF142 in nervous system development and add to the emergent list of zinc finger proteins that contribute to neurocognitive disorders.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    _2
$a kohortové studie $7 D015331
650    _2
$a výpočetní biologie $x metody $7 D019295
650    _2
$a vývojové poruchy u dětí $x genetika $7 D002658
650    _2
$a dystonie $x genetika $7 D004421
650    _2
$a rodina $7 D005190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mentální retardace $x genetika $7 D008607
650    _2
$a mutace $7 D009154
650    _2
$a missense mutace $7 D020125
650    _2
$a neurovývojové poruchy $x genetika $7 D065886
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a záchvaty $x genetika $7 D012640
650    _2
$a poruchy řeči $x genetika $7 D013064
650    _2
$a trans-aktivátory $x genetika $x metabolismus $7 D015534
650    _2
$a sekvenování exomu $7 D000073359
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zech, Michael $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. Institut für Humangenetik, Technische Universität München, Munich, Germany.
700    1_
$a Morgan, Angela T $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.
700    1_
$a Amor, David J $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.
700    1_
$a Skorvanek, Matej $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
700    1_
$a Khan, Tahir N $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
700    1_
$a Hildebrand, Michael S $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
700    1_
$a Jackson, Victoria E $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
700    1_
$a Scerri, Thomas S $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
700    1_
$a Coleman, Matthew $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
700    1_
$a Rigbye, Kristin A $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
700    1_
$a Scheffer, Ingrid E $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia. University of Melbourne Department of Paediatrics, Royal Children's Hospital, and Florey and Murdoch Children's Research Institute, Parkville, VIC, Australia.
700    1_
$a Bahlo, Melanie $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
700    1_
$a Wagner, Matias $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. Institut für Humangenetik, Technische Universität München, Munich, Germany.
700    1_
$a Lam, Daniel D $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
700    1_
$a Berutti, Riccardo $u Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
700    1_
$a Havránková, Petra $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
700    1_
$a Fečíková, Anna $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
700    1_
$a Strom, Tim M $u Institut für Humangenetik, Technische Universität München, Munich, Germany. Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
700    1_
$a Han, Vladimir $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
700    1_
$a Dosekova, Petra $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
700    1_
$a Gdovinova, Zuzana $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
700    1_
$a Laccone, Franco $u Institute of Medical Genetics, Medical School of Vienna, Vienna, Austria.
700    1_
$a Jameel, Muhammad $u Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
700    1_
$a Mooney, Marie R $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA.
700    1_
$a Baig, Shahid M $u Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
700    1_
$a Jech, Robert $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
700    1_
$a Davis, Erica E $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA.
700    1_
$a Katsanis, Nicholas $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. nicholas.katsanis@duke.edu.
700    1_
$a Winkelmann, Juliane $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. juliane.winkelmann@tum.de. Institut für Humangenetik, Technische Universität München, Munich, Germany. juliane.winkelmann@tum.de. Lehrstuhl für Neurogenetik, Technische Universität München, Munich, Germany. juliane.winkelmann@tum.de. Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. juliane.winkelmann@tum.de.
773    0_
$w MED00186213 $t Genetics in medicine : official journal of the American College of Medical Genetics $x 1530-0366 $g Roč. 21, č. 11 (2019), s. 2532-2542
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31036918 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130251 $b ABA008
999    __
$a ok $b bmc $g 1595840 $s 1114197
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 21 $c 11 $d 2532-2542 $e 20190430 $i 1530-0366 $m Genetics in medicine $n Genet Med $x MED00186213
GRA    __
$a P50 DK096415 $p NIDDK NIH HHS $2 United States
GRA    __
$a R01 HD042601 $p NICHD NIH HHS $2 United States
GRA    __
$a R01 MH106826 $p NIMH NIH HHS $2 United States
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...